Minerva Neurosciences (NERV) Total Non-Current Liabilities (2013 - 2026)

Minerva Neurosciences' Total Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $283.1 million for Q1 2026.

• Quarterly Total Non-Current Liabilities rose 14437.98% year-over-year to $283.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $283.1 million (up 14437.98% YoY) and the FY2025 annual result came in at $173.8 million, up 176.52% from the prior year.
• Total Non-Current Liabilities was $283.1 million for Q1 2026 at Minerva Neurosciences, up from $173.8 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $283.1 million in Q1 2026 and bottomed at $1.4 million in Q4 2022.
• A 5-year average of $32.9 million and a median of $3.2 million in 2022 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities tumbled 55.04% — and 2026, when it jumped 14437.98%.
• Minerva Neurosciences' Total Non-Current Liabilities stood at $1.4 million in 2022, then surged by 142.49% to $3.3 million in 2023, then soared by 1781.11% to $62.8 million in 2024, then soared by 176.52% to $173.8 million in 2025, then surged by 62.92% to $283.1 million in 2026.
• Business Quant data shows NERV's Total Non-Current Liabilities at $283.1 million in Q1 2026, $173.8 million in Q4 2025, and $2.7 million in Q3 2025.